5-Nitroquinoline-8-carbonitrile
CAS : 205046-59-9
Ref. 3D-FIA04659
1g | Arrêté | ||
5g | Arrêté | ||
100mg | Arrêté | ||
250mg | Arrêté | ||
500mg | Arrêté |
Informations sur le produit
5-Nitroquinoline-8-carbonitrile is a cysteine inhibitor that binds to the active site of cathepsin, a protease enzyme. It also inhibits other cysteine proteases, including pyridine nucleotide and nitroxoline. 5-Nitroquinoline-8-carbonitrile has shown efficacy against pathological conditions characterized by excessive extracellular matrix degradation such as arthritis and atherosclerosis. This drug may also have therapeutic potential as an anti-inflammatory agent in the treatment of inflammatory disorders, such as rheumatoid arthritis.